Vital SignsVital SignsCheck your MP →
PCRDavid James — no licensed photograph is available, so the sector leader plate is shown instead.

Sector leader

David James

Director of Patient Projects and Influencing, Prostate Cancer Research

Prostate Cancer Research is based in Holborn and St Pancras (London) — the organisation’s base, not a personal address.

Press citations

2

Topics

2

Cancer

Last quoted

Sept 2026

first cited Aug 2026

David James: key facts

Kind of voice
Sector leader
Role
Director of Patient Projects and Influencing
Organisation
Prostate Cancer Research
Organisation based in
Holborn and St Pancras
Quoted on
Cancer, Hospital discharge / bed-blocking
Tracked press citations
2
Most recently quoted
30 Sept 2026
First quoted
27 Aug 2026

Who David James is

David James is Director of Patient Projects and Influencing at Prostate Cancer Research (PCR), a UK charity focused on advancing research and equitable access to prostate cancer diagnosis, treatment and care. He leads the charity's Patient Projects team, which delivers initiatives including the Infopool patient information platform and the Prostate Progress programme, and also heads its Influencing department, building a coalition of politicians, policymakers, clinicians, industry leaders and patients. He has worked within health and medical research charities for over 18 years, with a background spanning tobacco control, organ donation, CPR skills, new treatments, digital health, and policy on how scientific evidence informs medicines regulation. In press coverage, he has argued that real-world UK evidence shows the harms of prostate cancer treatment are overstated and the benefits understated, and has publicly called for a targeted prostate cancer screening programme. He has appeared on Sky News discussing prostate cancer screening and has been quoted in outlets including the New Statesman and national newspapers on screening policy and health inequalities.

“This is a shocking betrayal and backward step that will condemn thousands more men each year to a late and incurable diagnosis.”

References for this biography

  1. 1.Our People – Prostate Cancer Research — Confirms David James's role, responsibilities (Patient Projects team and Influencing department), and career background in health and medical research charities for over 18 years
  2. 2.The prostate cancer conundrum – New Statesman, April 2026 — Press quote confirming role title and his public position on prostate cancer screening evidence
  3. 3.CF supports Prostate Cancer Research study into targeted screening – Consultancy.uk, August 2026 — Confirms role title and his leadership of PCR's targeted prostate cancer screening study
  4. 4.PCR in the News – Prostate Cancer Research — Confirms Sky News appearances on prostate cancer screening and role as Director of Patient Projects and Influencing
  5. 5.Contact information: PROSTATE CANCER RESEARCH – Charity Commission — Confirms registered head office address (Suite 2, 23–24 Great James Street, London, WC1N 3ES), phone number and general email for Prostate Cancer Research (charity no. 1156027)
  6. 6.The Infopool: Empowering Patients and Bridging Gaps in Prostate Cancer Care — Confirms David James as Director of Patient Projects at PCR and his role in developing the Infopool platform

Notable achievements

  • Led development and launch of the Infopool, an interactive patient information and education platform for people affected by prostate cancer, including a clinical trials finder Source ↗
  • Oversaw PCR's targeted prostate cancer screening study, supported by NHS data analysis from consultancy CF, examining testing activity, costs, workforce requirements and diagnostic pathways across the UK Source ↗
  • Appeared on Sky News to publicly advocate for prostate cancer screening, alongside a prostate cancer patient, as part of PCR's 'Proactive for your Prostate' campaign Source ↗
  • Quoted in the New Statesman (April 2026) challenging the UK National Screening Committee's position on large-scale prostate cancer screening, citing real-world UK evidence on treatment harms and benefits Source ↗

What David James has said

  • “We think that what we've demonstrated is that such a screening programme is cost effective and in fact delivers a positive socioeconomic benefit to the country as a whole, and that it won't overwhelm the NHS.”

    director of patient projects and influencing at Prostate Cancer Research · Hospital discharge / bed-blocking · 27 Aug 2026 · ‘Better and cheaper’: the case for prostate cancer screening among black men ↗

Where David James has been quoted

  1. Men lose right to prostate cancer testtelegraph.co.uk · 30 Sept 2026
  2. ‘Better and cheaper’: the case for prostate cancer screening among black mentheguardian.com · 27 Aug 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

Contact & links

Organisational contact points only, each taken from a page the organisation publishes itself. No personal or direct contact details are held or shown.

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.